OmniAb (OABI) Capital Expenditures (2022 - 2026)
OmniAb's (OABI) quarterly Capital Expenditures came in at $167000.0 in Q1 2026, down 20.1% year-on-year from $209000.0 in Q1 2025, and down 84.49% on a QoQ basis from $1.1 million in Q4 2025.
OmniAb (OABI) Capital Expenditures (2022 - 2026) Analysis & Trends
OmniAb (OABI) has 5 years of Capital Expenditures data on file, last reported at $167000.0 in Q1 2026.
- On a quarterly basis, Capital Expenditures fell 20.1% year-over-year to $167000.0 in Q1 2026; TTM through Mar 2026 was $523000.0, a 67.72% decrease from a year earlier, with the FY2025 full-year figure at $565000.0, down 69.87% from the prior year.
- Capital Expenditures for Q1 2026 stood at $167000.0, down from $1.1 million in the prior quarter.
- Over the last five years, Capital Expenditures for OABI reached as high as $2.5 million in Q4 2022 and fell as low as -$5.4 million in Q3 2022.
- Historically, Capital Expenditures has averaged $238941.2 across 5 years, with a median of $317000.0 in 2023.
- On a YoY basis, Capital Expenditures climbed as much as 537.74% in 2024 and fell as far as 2810.39% in 2024.
- Year by year, Capital Expenditures stood at $2.5 million in 2022, then tumbled by 79.04% to $533000.0 in 2023, then soared by 357.6% to $2.4 million in 2024, then sank by 55.84% to $1.1 million in 2025, then tumbled by 84.49% to $167000.0 in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $167000.0 in Q1 2026, $1.1 million in Q4 2025, and -$886000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | OmniAb | 261.62 Mn | 212.55 Mn | 14.41 Mn | 167,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 167,000.00 |
| Mar 31, 2026 | 167,000.00 |
| Dec 31, 2025 | 1.08 Mn |
| Dec 31, 2025 | 1.08 Mn |
| Sep 30, 2025 | -886,000.00 |
| Sep 30, 2025 | -886,000.00 |
| Jun 30, 2025 | 165,000.00 |
| Jun 30, 2025 | 165,000.00 |
| Mar 31, 2025 | 209,000.00 |
| Mar 31, 2025 | 209,000.00 |
| Dec 31, 2024 | 2.44 Mn |
| Dec 31, 2024 | 2.44 Mn |
| Sep 30, 2024 | -2.24 Mn |
| Sep 30, 2024 | -2.24 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 464,000.00 |
| Mar 31, 2024 | 464,000.00 |
| Dec 31, 2023 | 533,000.00 |
| Dec 31, 2023 | 533,000.00 |